Cole Steven W, Nagaraja Archana S, Lutgendorf Susan K, Green Paige A, Sood Anil K
Department of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine, University of California, Los Angeles (UCLA) Molecular Biology Institute, 11-934 Factor Building, UCLA School of Medicine, Los Angeles California 90095-1678, USA; and the Jonsson Comprehensive Cancer Center, UCLA, 8-684 Factor Building, Box 951781, Los Angeles, California 90095-1781, USA.
Department of Gynecologic Oncology; and the Department of Cancer Biology, University of Texas M. D. Anderson Comprehensive Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.
Nat Rev Cancer. 2015 Sep;15(9):563-72. doi: 10.1038/nrc3978.
The peripheral autonomic nervous system (ANS) is known to regulate gene expression in primary tumours and their surrounding microenvironment. Activation of the sympathetic division of the ANS in particular modulates gene expression programmes that promote metastasis of solid tumours by stimulating macrophage infiltration, inflammation, angiogenesis, epithelial-mesenchymal transition and tumour invasion, and by inhibiting cellular immune responses and programmed cell death. Haematological cancers are modulated by sympathetic nervous system (SNS) regulation of stem cell biology and haematopoietic differentiation programmes. In addition to identifying a molecular basis for physiologic stress effects on cancer, these findings have also identified new pharmacological strategies to inhibit cancer progression in vivo.
已知外周自主神经系统(ANS)可调节原发性肿瘤及其周围微环境中的基因表达。特别是ANS交感神经分支的激活,通过刺激巨噬细胞浸润、炎症、血管生成、上皮-间质转化和肿瘤侵袭,以及抑制细胞免疫反应和程序性细胞死亡,来调节促进实体瘤转移的基因表达程序。血液系统癌症受交感神经系统(SNS)对干细胞生物学和造血分化程序的调节。除了确定生理应激对癌症影响的分子基础外,这些发现还确定了在体内抑制癌症进展的新药理学策略。